你即將離開本站

並前往https://www.ecrjournal.com/video-index/aha-2021-late-breaker-discussion-empulse-trial

AHA 2021 Late-breaker Discussion: The EMPULSE Trial

Presented first at AHA 2021, the trial showed that that empagliflozin was beneficial at reducing adverse events among acute decompensated heart ...

確定！ 回上一頁

查詢 「EMPULSE trial」的人也找了：

  1. DELIVER trial
    2.
  2. EMPULSE trial
    3.
  3. EMPEROR trial
    4.
  4. soloist-whf
    5.
  5. EMPULSE empa
    6.
  6. Empulse trial Nature Medicine
    7.
  7. INBUILD trial
    8.
  8. CHIEF-HF Canagliflozin
    9.